KM
Kelly Michael Aaron
Director
OFFICERF
Insider track record
ExecutiveAcross 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the detailed record of transactions filed by Kelly Michael Aaron, Director. Insider active across 4 companies, notably DMC Global Inc.. Cumulatively, 20 filings have been recorded. History available since 12 May 2021. The latest transaction was disclosed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations20 total
16,937 shares0Common StockSEC:0001769668-26-000002:0
16,937 shares0Common StockSEC:0001769668-26-000002
17,580 shares0Common StockSEC:0000034067-25-000104:0
5,518 shares0Common StockSEC:0000034067-25-000034:0
11,336 shares0Common StockSEC:0001077183-24-000131:0
11,847 shares0Common StockSEC:0000950170-24-071005:0
9,520 shares0Common StockSEC:0000034067-24-000085:0
8,584 shares0Common StockSEC:0001209191-23-036429:0
7,086 shares0Common StockSEC:0000034067-23-000097:0
15,556 shares0Common StockSEC:0001077183-22-000113:0
12,671 shares0Common StockSEC:0001209191-22-035831:0
5,006 shares0Common StockSEC:0000034067-22-000076:0
4,610 shares0Common StockSEC:0001567619-21-012874:0
4,610 shares0Common StockSEC:0001567619-21-012874
10,115 shares0Common StockSEC:0001209191-21-040387
10,115 shares0Common StockSEC:0001209191-21-040387:0
3,081 shares0Common StockSEC:0001077183-21-000161:0
3,081 shares0Common StockSEC:0001077183-21-000161
1,888 shares0Common StockSEC:0000034067-21-000077
1,888 shares0Common StockSEC:0000034067-21-000077:0
About Kelly Michael Aaron
Michael Aaron Kelly is a Director at DMC Global Inc., Neogenomics Inc., and Amicus Therapeutics, Inc. In this role, he participates in strategic decision-making and the direction of operations for these companies. Kelly brings his expertise to guide growth and innovation initiatives, thereby contributing to the success of each organization.